Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Jula Veerapong

Dr. Jula Veerapong

Associate Professor, UC San Diego

Surgical oncologist Dr. Jula Veerapong specializes in treating surface malignancies such as peritoneal mesothelioma at the University of California San Diego School of Medicine.

Get in touch
Jump to a Topic:

About Jula Veerapong

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Research Excellence icon

    Excellence in Research

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

  • Board Certified icon

    Board Certified in Medical Oncology

Veerapong performs cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC), a combination that has worked well for patients with mesothelioma cancer.

In 2017, he joined the staff at Moores Cancer Center, which has been using the HIPEC procedure for more than a decade.

Veerapong previous served for six years at the St. Louis University School of Medicine, where he started and developed a HIPEC program as director of the Surface Malignancies Program.

He was first trained in the procedure during his fellowship at the University of Texas MD Anderson Cancer Center.

HIPEC typically follows a complete cytoreduction of tumor cells in the abdominal cavity. It involves circulating a heated chemotherapy solution through the abdomen for 90 minutes and is designed to kill any microscopic tumor cells that evaded the surgeon.

Unlike systemic chemotherapy, HIPEC delivers the drug directly to the affected area and decreases the toxicity on other parts of the body.

The procedure has changed the way a diagnosis of peritoneal mesothelioma is perceived, often more than doubling the expected survival time of patients. It also has been used successfully with colorectal and appendix cancers at the UC San Diego School of Medicine.

Veerapong leads an Enhanced Recovery After Surgery Program for patients who have undergone HIPEC. The program is designed to enhance and streamline care and recovery by establishing protocols for patients and staff during the pre-admission, pre-operative, inter-operative and post-operative stages.

Contributing to the Cancer Treatment Field

Veerapong specializes in a variety of gastrointestinal malignancies. He treats those with appendiceal cancer, colorectal cancer, gynecologic malignancies and pseudomyxoma peritonei.

His research has included minimally-invasive techniques and the utilization of HIPEC for ovarian cancer. As an associate professor, he also works with the residency and fellowship programs at UC San Diego.

Veerapong earned his degree from the University of Illinois Urbana-Champaign College of Medicine. He completed his residency in general surgery at the University of Chicago Medical Center.

He speaks regularly at national and international medical conventions, and his work has been published in Clinical Cancer Research, Cancer Research and the Journal of Gastrointestinal Surgery.

He is a member of the Society of Surgical Oncology and the Association for Academic Surgery. In St. Louis, he was honored with the Vallee Willman Award for Excellence in Surgical Education for his work with residents.

See More Top Mesothelioma Doctors

Disclaimer: Dr. Jula Veerapong has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Daniel King, Content Writer for
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. UC San Diego Health. (n.d.). Jula Veerapong, MD.
    Retrieved from:
  2. UC San Diego School of Medicine. (2017, November 16). Press Release. Team HIPEC: Expanding Use of Heated Intraperitoneal Chemoperfusion. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 4, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now